Two-photon imaging of cell-specific fluorophores in transgenic mice – an exploratory tool to study mechanisms of white matter injury by Valentino, Mario et al.
recipient mortality due to overwhelming sepsis, the rest were well after a 
median follow-up of 36 months postoperatively.  The serum creatinine 
had fallen from a median of 785umol/l (range1168-446) pre-operatively to 
138umol/l (range 285-96) at one year post-operatively.  There were 2 cases 
of acute rejection, 2 other of borderline acute rejection and 2 further cases 
developed chronic rejection.  No donor mortality.
Conclusion: Living-donor renal transplantation can safely be performed 
even in such a small institution such as Malta. 
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Juvenile Huntington’s disease in Malta
A Cuschieri1, A Galea-Debono2, E Said3 
1Department of Anatomy, University of Malta, 
2Neurology, St Luke’s Hospital, 
3Clinical Cytogenetics, St Luke’s Hospital
Huntington’s disease is an autosomal dominant progressive neurological 
condition characterized by involuntary movements and dementia. The age 
of onset is related to the number of (CAG)n trinucleotide repeats in the 
Huntington gene. Rarely, the disease manifests itself first during childhood 
or adolescence as juvenile Huntington’s disease, and occurs when gene 
amplification occurs increasing greatly the number of repeats. Over the 
11 year period from 1994 to 2006, three cases of Juvenile Huntington’s 
disease were recorded from among the families with Huntington’s disease 
referred to the genetic clinic for genetic counselling, pre-symptomatic DNA 
testing or diagnostic DNA testing. The affected individuals were three boys 
of ages 10, 14 and 21 years at the time of confirmation of the diagnosis by 
DNA tests. They were from three different families with strong family 
histories of Huntington’s disease. The presenting features of the juvenile 
cases were distinct from those of adult-onset Huntington’s disease. The 
most characteristic initial manifestations were behavior disorders and a 
characteristic speech in which words were uttered very rapidly in short 
phrases separated by short pauses. The speech disorder may be one of the 
earliest manifestations of motor dysfunction. The other motor manifestations 
were rigidity and myotonia. Choreiform movements developed later in the 
course of the disease in one of the youngest of the affected young individuals. 
All three individuals were males, had over 60 (CAG)n repeats and had 
inherited the gene from their fathers, with amplification of the trinucleotide 
repeats occurring in the process. Diagnosis of juvenile Huntington’s disease 
presents the ethical problems of informed consent and genetic testing in 
minors, and the delicate procedure of post-test counseling. 
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Two-photon imaging of cell-specific 
fluorophores in transgenic mice - an 
exploratory tool to study mechanisms of 
white matter injury
M Valentino1,2, MP Goldberg1
1 Department of Neurology, Washington University in St Louis, MO and 
Hope Center for Neurological Disorders, 
2Department of Physiology and Biochemistry, University of Malta
Relatively little is known about specific pathways leading to structural 
and functional disruption of axons and glial cells in white matter. Because 
focal cerebral ischemia in humans damages both gray and white matter, 
an understanding of white matter injury is important in devising potential 
therapeutic approaches. We have developed a novel brain slice model from 
transgenic mice under control of cell-specific promoters to understand 
interactions between oligodendrocytes and axons under high resolution two-
photon microscopy. Our data extends over previous findings the vulnerability 
of oligodendrocytes and axons both in culture and in slice preparations to 
glutamate toxicity during stroke and hypoglycemia. Conditions as different 
as stroke, trauma, perinatal brain injury, and multiple sclerosis may share 
common mechanisms of white matter injury. 
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Are chondroitin and glucosamine in 
combination effective in the treatment of 
osteoarthritic pain?
MR Sammut
Department of Family Medicine, University of Malta Medical School
Aim: As non-steroidal anti-inflammatory drugs today are contraindicated 
for osteoarthritic pain in elderly patients with cardiovascular disease due 
to their adverse effects, a review of the evidence was performed regarding 
the use of oral forms of chondroitin and glucosamine in combination as an 
alternative treatment.
Method: An internet review for available evidence was carried out of 
secondary sources (reviews or meta-analyses of primary studies in the 
Cochrane Database of Systematic Reviews and the Database of Abstracts 
of Reviews of Effects) and of primary sources (randomised controlled 
trials in Medline through PubMed and in the Cochrane Central Register of 
Controlled Trials), followed by a critical evaluation of the results for validity, 
reliability and applicability.
Results: Three relevant randomised controlled trials with valid, reliable 
and applicable results were identified.
Conclusion: Chondroitin and glucosamine in combination were found to 
significantly reduce pain in mild to moderate OA of the knee measured by 
the global pain visual analogue scale, and in moderate to severe knee OA 
measured by the WOMAC Scale, while significantly improving disability in 
mild to moderate knee OA as measured by the Lequesne Index.
Discussion: If the results are generalisable to osteoarthritis of all joints, 
there are good indications that combined chondroitin-glucosamine in 
purified therapeutic doses should help care for osteoarthritis patients safely 
and at modest expense. In order to facilitate any possible recommendations 
for their use in clinical practice, long-term and larger studies are needed 
to elaborate more definite results and investigate their preventive use as 
disease-modifying osteoarthritis drugs.
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A survey of Paget’s disease of bone in Malta
B Coleiro, C Mallia
Department of Medicine, St Luke’s Hospital, Malta.
Paget’s disease of bone is commonly encountered in the Maltese population. 
A survey has been conducted on 20 patients with this condition seen at 
the Medical Outpatient Department/St Luke’s Hospital during the first 6 
months of 2007. Various aspects of the disease have been analysed: age and 
sex distribution, familial aggregates, mode of presentation, complications, 
pattern of bone involvement and a semi-quantitative assay of disease 
activity as measured by radioisotope bone scintigraphy and serum alkaline 
phosphatase levels. These characteristics are being compared to previously 
published surveys of Paget’s disease in other countries.
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Biological therapy in rheumatic disease: 
five year experience in Malta
C Mallia, B Coleiro
Department of Medicine, Division of Rheumatology, St Luke’s Hospital, 
Guardamangia
Advances in understanding the pathogenesis of many rheumatological 
disorders over the past decade have resulted in remarkable advances in 
therapeutic options for many patients suffering from these disorders. The 
pro-inflammatory cytokine tumour necrosis factor alpha (TNF-alpha) has 
been shown to be a key mediator in a number of inflammatory disorders, 
and the development of TNF-alpha inhibitors has proved to be a major 
therapeutic advance. Initially licensed for use in rheumatoid arthritis, 
TNF-alpha inhibitors have been subsequently approved for a number of 
other inflammatory arthritides as well, including ankylosing spondylitis 
and psoriatic arthritis. Case reports and case series have suggested 
favourable results with these agents in other connective tissue diseases, 
including various types of vasculitis. Another interesting area in the field of 
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